Shares of ANGLE plc (LON:AGL – Get Free Report) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 2.35 and traded as high as GBX 2.90. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares changing hands.
ANGLE Trading Down 11.3%
The company has a debt-to-equity ratio of 25.25, a current ratio of 2.76 and a quick ratio of 6.17. The company has a market capitalization of £7.58 million, a price-to-earnings ratio of -0.49 and a beta of 0.22. The business’s 50 day simple moving average is GBX 2.35 and its 200 day simple moving average is GBX 2.35.
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Read More
- Five stocks we like better than ANGLE
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
